Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
The Cochrane Database of Systematic Reviews|March 19, 2010
Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in childrenManou S de Lijster, Rosemarijn M Bergevoet, Elvira C van Dalen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2007
Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastomaArjen Koppen, Rachida Ait-Aissa, Jan Koster, et al.
Frontiers in Immunology|November 2, 2016
The High Prevalence of Functional Complement Defects Induced by ChemotherapyMischa P Keizer, Angela M Kamp, Cathelijn Aarts, et al.
Pediatric Blood & Cancer|May 19, 2015
Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecanKathelijne C J M Kraal, Godelieve A M Tytgat, Berthe L F van Eck-Smit, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2009
Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cellsJan J Molenaar, Marli E Ebus, Dirk Geerts, et al.
Radiology|August 30, 2013
Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments?Reineke A Schoot, Kieran McHugh, Rick R van Rijn, et al.
The Cochrane Database of Systematic Reviews|January 7, 2015
Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in childrenElvira C van Dalen, Manou S de Lijster, Lieve Gj Leijssen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activityLaurel T Bate-Eya, Hinco J Gierman, Marli E Ebus, et al.
Haematologica|June 12, 2013
Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cellsStefanie A Hartsink-Segers, Carla Exalto, Matthew Allen, et al.
BMC Cancer|July 14, 2012
Identification of BIRC6 as a novel intervention target for neuroblastoma therapyFieke Lamers, Linda Schild, Jan Koster, et al.
Pageof 13